Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Sep 17, 2019

Mylan Expands Oncology Portfolio with Launch of Generic Faslodex® Injection, a Treatment for Advanced Breast Cancer

Jul 29, 2019

Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World's Need for Medicine

Jul 29, 2019

Statement from Mylan's Board of Directors Regarding Retirement of CEO and Board Member Heather Bresch in Conjunction with the Combination of Mylan and Upjohn, a Division of Pfizer

Jul 29, 2019

Mylan Reports Second Quarter 2019 Results

Jul 08, 2019

Mylan and Atomo Diagnostics Announce WHO Prequalification Approval for Mylan HIV Self Test

Jun 14, 2019

Theravance Biopharma and Mylan Expand YUPELRI® (revefenacin) Development and Commercialization Agreement to Include China and Adjacent Territories

May 20, 2019

Theravance Biopharma and Mylan Present Additional YUPELRI® (revefenacin) Phase 3 Data Analysis at the 2019 ATS International Conference

May 18, 2019

Mylan Presents Equivalence and Device Usability Data on Wixela™ Inhub™ Compared to Advair Diskus® at American Thoracic Society International Conference

May 17, 2019

Mylan to Host Investor Day on July 31, 2019 in New York City

May 15, 2019

Mylan and Biocon to Present Final Overall Survival Data for Ogivri™ (trastuzumab-dkst), a biosimilar to Herceptin®, at the American Society of Clinical Oncology (ASCO) Annual Meeting

Pagination

First page
Previous page
…
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Page 10
Page 11
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2024 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.